Insider Transactions in Q1 2021 at Strongbridge Biopharma PLC (SBBP)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 03
2021
|
Richard S Kollender President and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+19.63%
|
-
|
|
Feb 22
2021
|
Fredric J. Cohen Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,978
-3.19%
|
$20,934
$3.62 P/Share
|
|
Feb 22
2021
|
Stephen J Long Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,062
-4.05%
|
$21,186
$3.62 P/Share
|
|
Feb 22
2021
|
Robert Matthew Lutz Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,978
-3.71%
|
$20,934
$3.62 P/Share
|
|
Feb 22
2021
|
Scott L. Wilhoit Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,121
-4.94%
|
$21,363
$3.62 P/Share
|
|
Jan 07
2021
|
John Johnson Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
491,000
+32.64%
|
-
|
|
Jan 07
2021
|
Fredric J. Cohen Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
181,000
+45.26%
|
-
|
|
Jan 07
2021
|
Richard S Kollender President and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
147,500
+37.34%
|
-
|
|
Jan 07
2021
|
Stephen J Long Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
143,500
+45.17%
|
-
|
|
Jan 07
2021
|
Robert Matthew Lutz Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
147,500
+43.92%
|
-
|
|
Jan 07
2021
|
Scott L. Wilhoit Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
113,000
+43.94%
|
-
|